scPharmaceuticals
Lexington
About scPharmaceuticals
ScPharmaceticals is creating innovative and important new therapeutic options by administering drugs subcutaneously using a convenient two-component delivery system suitable for patient self-administration. In February 2013 scPharmaceuticals was formed to continue the groundbreaking work of SpringLeaf Therapeutics, a Boston area company that started in 2007. scPharmaceuticals targets the untapped opportunity of treating patients with serious medical conditions with a convenient safe and comfortable subcutaneous administration of a drug. This is therapeutically equivalent to intravenous administration while avoiding the cost, burden, and risks associated with intravenous administration.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $456.6M
- Funding stage: M&A
- Last round: Post-IPO Debt (Aug 2024)
- Ticker: nasdaq:SCPH
- Website: scpharmaceuticals.com
- Phone: (617)517-0730
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/scpharmaceuticals-160233 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.